Goldman downgrades Charles River Labs (CRL -1.7%) to Sell from Neutral and lowers its price target to $38 from $44. Analyst Robert Jones cites (among other factors) "recent … channel checks [which] indicate still subdued early-stage spend and excess capacity as pharma prioritizes late-stage pipelines."
Goldman downgrades Charles River Labs (CRL -1.7%) to Sell from Neutral and lowers its price...
Recommended For You
More Trending News
About CRL Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CRL | - | - |
Charles River Laboratories International, Inc. |